Skip to main content

Table 5 Results of Immunobead RT-PCR screening of peripheral blood samples from the 16 patients with head and neck cancers included in this study for marker expression.

From: Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma

 

Marker 1

Marker 2

 

ESX

ESX

ESX

ESX

EGFR

EGFR

EGFR

EGFR

P#

BF 1

BF 2

AF 1

AF 2

BF 1

BF 2

AF 1

AF 2

1

   

POS

    

2

        

3

POS

       

4

POS

    

POS

POS

 

5

POS

       

6

POS

POS

 

POS

  

POS

POS

7

POS

POS

POS

POS

  

POS

POS

8

POS

POS

 

POS

POS

POS

POS

 

9

     

POS

POS

POS

10

       

POS

11

POS

POS

  

POS

 

POS

POS

12

POS

       

13

  

POS

POS

POS

POS

  

14

        

15

POS

   

POS

 

POS

 

16

      

POS

 
 

Marker 3

Marker 4

 

EphB4

EphB4

EphB4

EphB4

CK19

CK19

CK19

CK19

P#

BF 1

BF 2

AF 1

AF 2

BF 1

BF 2

AF 1

AF 2

1

     

POS

POS

 

2

POS

   

POS

POS

  

3

  

POS

 

POS

POS

POS

 

4

   

POS

 

POS

  

5

    

POS

POS

 

POS

6

POS

POS

 

POS

POS

POS

POS

POS

7

 

POS

POS

POS

POS

POS

POS

 

8

POS

POS

 

POS

POS

POS

POS

POS

9

POS

POS

  

POS

POS

POS

POS

10

  

POS

    

POS

11

POS

     

POS

POS

12

       

POS

13

POS

POS

 

POS

POS

POS

POS

 

14

        

15

 

POS

POS

  

POS

POS

 

16

    

POS

POS

 

POS

  1. P# denotes patient number. Duplicate samples taken before surgery (BF) or after surgery (AF) were screened for expression of the four markers ESX, EGFR, EphB4 and CK19. Samples that were positive for individual markers are indicated (POS).